INOVIO PHARMACEUTICALS, INC. Proceeds from Sale of Intangible Assets
INOVIO PHARMACEUTICALS, INC. (INO) reported Proceeds from Sale of Intangible Assets of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfIntangibleAssets · last filed 2020-03-12
- INOVIO PHARMACEUTICALS, INC. proceeds from sale of intangible assets for the quarter ending 2017-12-31 was $1.00M.
- INOVIO PHARMACEUTICALS, INC. proceeds from sale of intangible assets for the quarter ending 2017-09-30 was $0.00.
- INOVIO PHARMACEUTICALS, INC. proceeds from sale of intangible assets for the quarter ending 2016-12-31 was $0.00.
- INOVIO PHARMACEUTICALS, INC. proceeds from sale of intangible assets for the quarter ending 2016-09-30 was $0.00.
- INOVIO PHARMACEUTICALS, INC. proceeds from sale of intangible assets for fiscal 2019 was $0.00.
- INOVIO PHARMACEUTICALS, INC. proceeds from sale of intangible assets for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- INOVIO PHARMACEUTICALS, INC. proceeds from sale of intangible assets for fiscal 2017 was $1.00M, a 0.00% change from fiscal 2016.
- INOVIO PHARMACEUTICALS, INC. proceeds from sale of intangible assets for fiscal 2016 was $1.00M, a 0.00% change from fiscal 2015.
| Period end | Proceeds from Sale of Intangible Assets 3 month | Proceeds from Sale of Intangible Assets 6 month | Proceeds from Sale of Intangible Assets 9 month | Proceeds from Sale of Intangible Assets 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-12 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-03-12 | |||
| 2017-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $1.00M derived: sum of 2 quarters · filed 2020-03-12 | $1.00M 10-K · filed 2020-03-12 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $0.00 10-Q · filed 2017-11-08 | ||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-08 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $0.00 derived: sum of 2 quarters · filed 2019-03-12 | $1.00M 10-K · filed 2019-03-12 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $1.00M 10-Q · filed 2017-11-08 | ||
| 2016-06-30 | $1.00M 10-Q · filed 2017-08-08 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $0.00 derived: sum of 2 quarters · filed 2018-03-14 | $1.00M 10-K · filed 2018-03-14 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $1.00M 10-Q · filed 2016-11-09 | ||
| 2015-06-30 | $1.00M 10-Q · filed 2016-08-08 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $0.00 derived: sum of 2 quarters · filed 2017-03-15 | $0.00 10-K · filed 2017-03-15 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $0.00 10-Q · filed 2015-11-09 | ||
| 2014-06-30 | $0.00 10-Q · filed 2015-08-10 | |||
| 2013-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $1.00M derived: sum of 2 quarters · filed 2016-03-14 | $2.00M derived: sum of 3 quarters · filed 2016-03-14 | $2.00M 10-K · filed 2016-03-14 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $1.00M derived: sum of 2 quarters · filed 2014-11-10 | $1.00M 10-Q · filed 2014-11-10 | $1.00M derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $1.00M 10-Q · filed 2014-08-11 | $1.00M derived: sum of 3 quarters · filed 2015-03-16 | $1.50M derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-10 | $0.00 derived: sum of 2 quarters · filed 2015-03-16 | $500.00K derived: sum of 3 quarters · filed 2015-03-16 | $500.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $500.00K derived: sum of 2 quarters · filed 2015-03-16 | $500.00K derived: sum of 3 quarters · filed 2015-03-16 | $650.00K 10-K · filed 2015-03-16 |
| 2012-09-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $500.00K derived: sum of 2 quarters · filed 2013-11-12 | $650.00K 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $150.00K 10-Q · filed 2013-08-09 | ||
| 2012-03-31 | $150.00K 10-Q · filed 2013-05-10 | |||
| 2011-12-31 | $350.00K 10-K · filed 2014-03-17 | |||
| 2010-12-31 | $0.00 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |